Stone House Investment Management »

Myriad Genetics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 1.0k 21.32
2023-12-31 $19k 1.0k 19.14
2023-09-30 $16k 1.0k 16.04
2023-06-30 $23k 1.0k 23.18
2023-03-31 $23k 1.0k 23.23
2019-03-31 $5.0k 154 32.47

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)
Procter & Gamble Company (PG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Msci Emrg Chn (EMXC)

View all positions for Stone House Investment Management

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
Wellington Management Company
Glenview Captal Management
Millennium Management
Earnest Partners
Dimensional Fund Advisors
Bank of America Corporation
Artisan Partners Limited Partnership
Sei Investments
Disciplined Growth Investors
Geode Capital Management
Morgan Stanley
Nuveen Asset Management
Citadel Advisors

View all funds holding Myriad Genetics